Formulary status of sulfonylureas

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Mon, 11/16/2020 - 12:28
#1
Amaris Fuentes
Amaris Fuentes's picture
Offline
Last seen: 4 months 3 weeks ago
Joined: 11/13/2018 - 10:40
Formulary status of sulfonylureas

Good morning all -

We are exploring removing sulfonylureas off our formulary secondary to the risk for adverse effects. Reaching out to see if others have proceeded in this direction and, if so, what steps were taken to ensure policy was followed, non-formulary use was still safeguarded, and preventing hyperglycemia.

Thanks,

Amaris

Top